BackgroundRemission and recovery rates for people with first-episode psychosis (FEP)
remain uncertain. AimsTo assess pooled prevalence rates of remission and recovery in FEP …

Objective: The present guidelines address the pharmacotherapy of schizophrenia in adults
across different stages, phases, and symptom domains. Method: Guidelines were developed …

BACKGROUND: Preventing relapse is an essential element of early intervention in
psychosis, but relevant risk factors and precise relapse rates remain to be clarified. The aim …

Background: Cortisol and inflammatory markers have been increasingly reported as
abnormal at psychosis onset. The main aim of our study was to investigate the ability of …

The search for clinical outcome predictors for schizophrenia is as old as the field of
psychiatry. However, despite a wealth of large, longitudinal studies into prognostic factors …

Background The long-term consequences of discontinuing antipsychotic medication after
successful treatment of first-episode psychosis are not well studied. We assess the relation …

Objective: How long clinicians should wait before considering an antipsychotic ineffective
and changing treatment in schizophrenia is an unresolved clinical question. Guidelines …

In March 2005, the Remission in Schizophrenia Working Group (RSWG) proposed a
consensus definition of symptomatic remission in schizophrenia and developed specific …

Objective: To describe the longer-term clinical and functional outcome of a large,
epidemiologic representative cohort of individuals experiencing a first episode of psychosis …

The RSWG remission criteria are easy to apply and define an achievable and desirable
treatment goal. Measures of social and occupational functional outcome, quality of life and …